NCI Remembers Christopher Michejda
Dr. Michejda was a professor of chemistry at the University of Nebraska in Lincoln before coming to NCI-Frederick in 1978. He received his Ph.D. in physical-organic chemistry at the University of Rochester and then went on to a postdoctoral fellowship at Harvard University. At CCR, his initial focus on chemical carcinogenesis evolved into drug development; he used his talent in chemistry to find new drugs against cancer and viral diseases.
"Chris was a valuable collaborator who provided unselfish and thoughtful leadership for numerous intramural initiatives, including the Director's Innovation Award review panel, the Chemistry and Structural Biology Faculty, and several other faculties and committees," said Dr. Bob Wiltrout, CCR director. "Our thoughts and prayers are with his family, friends, and colleagues."
DCLG Applications Now Being Accepted
Application instructions can be found at http://deainfo.nci.nih.gov/advisory/dclg/applications/2007DCLGapplication.pdf. Information about DCLG is available at http://dclg.cancer.gov/. Applications must be postmarked by March 30. DCLG members can serve up to 4 years and terms of office will begin in July.
Cancer Survivorship Publications Available
The Institute of Medicine recently published proceedings from a workshop held in May 2006: Implementing Cancer Survivorship Care Planning: Workshop Summary. Information about the report is available at http://www.iom.edu/CMS/26765/39416.aspx.
New Cancer Information Pages Added to Web Site